A natural plant compound called Bletilla striata oligosaccharides (BSO) reduced fatty liver disease in mice by improving gut bacteria, strengthening intestinal protection, and decreasing liver inflammation. According to Gram Research analysis, high-dose BSO treatment reduced liver fat accumulation and performed as well as metformin, a standard medication, while showing a better safety profile. However, human studies are needed before BSO can be recommended as a treatment.
Researchers discovered that a natural compound called Bletilla striata oligosaccharides (BSO), derived from a traditional plant, may help reverse fatty liver disease caused by high-fat diets. In a study with mice, the compound worked by improving gut bacteria balance, strengthening the intestinal barrier, and reducing liver inflammation. The treatment was as effective as metformin, a common diabetes medication, but with fewer side effects. According to Gram Research analysis, this finding suggests BSO could become a new dietary supplement option for people struggling with metabolic fatty liver disease, a condition affecting millions worldwide.
Key Statistics
A 2026 research article published in Frontiers in Nutrition found that high-dose Bletilla striata oligosaccharides (BSO) reduced body weight gain, lowered fasting glucose levels, and decreased hepatic triglycerides in mice with high-fat diet-induced fatty liver disease.
According to the study, BSO treatment enriched beneficial gut bacteria including Lachnospiraceae and Oscillospiraceae while suppressing the hepatic TLR4/NF-κB inflammatory pathway, achieving results comparable to metformin treatment.
The research demonstrated that BSO restored intestinal barrier integrity by upregulating colonic tight junction proteins and activated the FXR/FGF15 signaling axis, improving bile acid metabolism in mice with metabolic-associated fatty liver disease.
The Quick Take
- What they studied: Whether a natural plant extract (BSO) could reverse fatty liver disease by changing gut bacteria and reducing liver inflammation
- Who participated: Laboratory mice fed a high-fat diet to develop fatty liver disease, then treated with different doses of BSO or metformin for 12 weeks
- Key finding: High-dose BSO reduced body weight gain, lowered blood sugar, decreased liver fat, and reduced liver inflammation as effectively as metformin treatment
- What it means for you: This suggests BSO could become a natural supplement option for fatty liver disease, though human studies are needed before it can be recommended as a treatment
The Research Details
Scientists created fatty liver disease in mice by feeding them a high-fat diet for 8 weeks. Then they gave some mice different amounts of BSO (a natural compound from a plant) or metformin (a standard medication) for 12 weeks while continuing the high-fat diet. They measured changes in body weight, blood sugar, liver fat, liver damage, and gut bacteria composition.
The researchers used advanced techniques to examine how BSO worked inside the body. They looked at the intestinal barrier (the protective lining of the gut), measured inflammation markers in the liver, analyzed the types of bacteria in the gut, and studied specific cellular pathways involved in fat storage and inflammation.
This approach allowed them to understand not just whether BSO worked, but exactly how it helped reverse the disease through multiple mechanisms in the gut-liver connection.
This research design is important because it goes beyond simply testing if something works—it reveals the actual mechanisms. Understanding how BSO helps the gut bacteria, strengthens intestinal protection, and reduces liver inflammation provides a roadmap for developing better treatments. The comparison to metformin shows whether this natural compound could be a viable alternative or complement to existing medications.
This was a controlled laboratory study with clear treatment groups and measurable outcomes. The researchers used multiple advanced techniques to verify their findings from different angles. However, this was conducted in mice, not humans, so results may not directly translate. The study was published in a peer-reviewed journal, indicating expert review of the methods and findings.
What the Results Show
The high-dose BSO treatment produced impressive results across multiple measures. Mice receiving BSO gained significantly less weight compared to untreated mice with fatty liver disease. Their fasting blood sugar levels dropped, indicating improved glucose control. Most importantly, the amount of fat stored in their livers decreased substantially, and markers of liver damage and inflammation were reduced.
BSO achieved these results through several interconnected mechanisms. First, it restored the integrity of the intestinal barrier—essentially repairing the protective lining of the gut. This prevented harmful substances from leaking into the bloodstream and triggering inflammation. Second, BSO changed the composition of gut bacteria, increasing beneficial types like Lachnospiraceae and Oscillospiraceae while reducing harmful species.
Third, BSO activated specific cellular pathways that reduce inflammation in the liver. It suppressed a key inflammatory pathway called TLR4/NF-κB, which is typically overactive in fatty liver disease. Fourth, BSO improved bile acid metabolism, which plays a crucial role in fat digestion and liver health.
When compared directly to metformin, a standard medication for metabolic disease, BSO performed comparably well while appearing to have a better safety profile with fewer side effects.
Beyond the main results, researchers discovered that BSO altered specific metabolites (chemical compounds) in the liver. Levels of a compound called confertifoline decreased while D-myo-inositol-4-phosphate increased, suggesting improved metabolic function. BSO also activated the FXR/FGF15 signaling pathway, which is important for regulating bile acids and fat metabolism. These secondary findings help explain why BSO works at the molecular level and suggest multiple pathways through which it could benefit liver health.
Previous research has shown that gut bacteria play a critical role in fatty liver disease, but few treatments specifically target the gut-liver connection. Most existing approaches focus on either reducing inflammation or improving insulin sensitivity, but not both simultaneously. This study is notable because BSO appears to work through multiple mechanisms at once—improving gut bacteria, strengthening the intestinal barrier, and reducing inflammation. This multi-target approach aligns with emerging understanding that fatty liver disease requires comprehensive treatment rather than single-pathway interventions.
The most significant limitation is that this research was conducted in mice, not humans. Mouse metabolism differs from human metabolism, and results don’t always translate directly. The study didn’t specify the exact number of mice used in each group, making it harder to assess statistical power. The research was conducted in a laboratory setting with controlled diets and conditions, which differs from real-world eating patterns and lifestyle factors. Additionally, the study only lasted 12 weeks of treatment, so long-term effects remain unknown. Finally, while BSO showed promise, human clinical trials are essential before it can be recommended as a medical treatment.
The Bottom Line
Based on this research, BSO shows promise as a potential supplement for fatty liver disease, but it’s too early for clinical recommendations. The evidence is strong in animal models (high confidence in the mechanism), but human studies are needed. If you have fatty liver disease, discuss with your doctor whether BSO supplements might be appropriate as a complementary approach alongside proven lifestyle changes like diet improvement and exercise. Do not replace metformin or other prescribed medications without medical guidance.
This research is most relevant to people with metabolic-associated fatty liver disease (MAFLD), particularly those who are overweight or have metabolic syndrome. It may also interest people seeking natural alternatives to pharmaceutical treatments. People with existing liver disease should consult their doctor before trying new supplements. This research is less immediately relevant to people without fatty liver disease, though it provides insights into gut health and metabolism that may have broader applications.
In the mouse study, significant improvements appeared after 12 weeks of treatment. If BSO were to be tested in humans, similar timelines might be expected, but this is speculative. Lifestyle changes like diet and exercise typically show benefits within 4-8 weeks, so BSO would likely need to be combined with these proven approaches. Long-term studies would be needed to determine if benefits persist over months or years.
Frequently Asked Questions
What is Bletilla striata and how does it help fatty liver disease?
Bletilla striata is a traditional plant whose oligosaccharides (natural sugars) improve gut bacteria balance, strengthen the intestinal barrier, and reduce liver inflammation. In mice studies, it reduced liver fat and performed as well as metformin medication with fewer side effects.
Can I take Bletilla striata oligosaccharides as a supplement for my fatty liver?
This research shows promise in mice, but human clinical trials haven’t been completed yet. Consult your doctor before starting any supplement. BSO might complement proven treatments like diet changes and exercise, but shouldn’t replace prescribed medications without medical guidance.
How does BSO compare to metformin for treating fatty liver disease?
In this mouse study, BSO performed comparably to metformin in reducing liver fat and inflammation. However, BSO appeared to have a better safety profile with fewer side effects. Human studies are needed to confirm whether this advantage holds in people.
How long does it take to see results from Bletilla striata treatment?
In the mouse study, significant improvements appeared after 12 weeks of treatment. If similar timelines apply to humans, you might expect to see benefits within 8-12 weeks when combined with diet and exercise changes, though individual results vary.
Is this research applicable to humans or just mice?
This research was conducted in mice, which have different metabolism than humans. While the findings are promising and the mechanisms are well-documented, human clinical trials are essential before BSO can be recommended as a medical treatment for fatty liver disease.
Want to Apply This Research?
- Track weekly body weight, fasting blood sugar levels (if you have a home glucose monitor), and subjective energy levels. Also monitor digestive health by noting any changes in digestion, bloating, or bowel regularity, as these reflect gut microbiota changes.
- If using BSO as a supplement, pair it with documented dietary improvements: photograph meals to track fat intake reduction, log daily steps to increase physical activity, and record weekly weight. Use the app to set reminders for consistent supplement timing and to log any digestive changes or side effects.
- Establish a baseline of current weight, energy levels, and digestive patterns. After starting BSO, check weight weekly and energy levels daily. Schedule monthly liver function blood tests with your doctor to monitor liver health markers. Create a 12-week tracking dashboard to visualize changes in weight, energy, and digestive symptoms, comparing to the 12-week treatment period used in this research.
This research was conducted in laboratory mice and has not been tested in humans. Bletilla striata oligosaccharides are not currently approved by the FDA as a medical treatment for fatty liver disease. Do not use BSO as a replacement for prescribed medications or medical treatment without consulting your healthcare provider. If you have fatty liver disease or metabolic concerns, speak with your doctor before starting any new supplement. This article is for educational purposes and should not be considered medical advice. Always consult qualified healthcare professionals before making changes to your treatment plan.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.